Fei Yang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 17

Top Venues

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

NPJ breast cancer

University of Texas MD Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center Feb 01 2014

United States

Assistant Professor :: Translational Molecular Pathology

Publications

Xuan Liu, Zhongqi Ge, Fei Yang, Alejandro Contreras, Sanghoon Lee, Jason B White, Yiling Lu, Marilyne Labrie, Banu K Arun, Stacy L Moulder, Gordon B Mills, Helen Piwnica-Worms, Jennifer K Litton, Jeffrey T Chang
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers. NPJ breast cancer 8 (1) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Tapsi Kumar, Evthokia A Hobbs, Fei Yang, Jeffrey T Chang, Alejandro Contreras, Edwin Roger Parra Cuentes, Haven R Garber, Sanghoon Lee, Yiling Lu, Marion E Scoggins, Beatriz E Adrada, Gary J Whitman, Banu K Arun, Elizabeth A Mittendorf, Jennifer K Litton
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiangjie Sun, Jie Zhai, Baohua Sun, Edwin Roger Parra Cuentes, Mei Jiang, Wencai Ma, Jing Wang, Anthony M Kang, Kasthuri Kannan, Renganayaki Pandurengan, Shanyu Zhang, Luisa Maren Solis, Cara L Haymaker, Maria Gabriela Raso, Julia Mendoza Perez, Aysegul A Sahin, Ignacio I Wistuba, Clinton Yam, Jennifer K Litton, Fei Yang
Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (2021)
Clinton Yam, Er-Yen Yen, Jeffrey T Chang, Roland L Bassett, Gheath Alatrash, Haven R Garber, Lei Huo, Fei Yang, Anne V Philips, Qing-Qing Ding, Bora Lim, Naoto Tada Ueno, Kasthuri Kannan, Xiangjie Sun, Baohua Sun, Edwin Roger Parra Cuentes, William Fraser Symmans, Jason B White, Elizabeth Ravenberg, Sahil B Seth, Jennifer L Guerriero, Gaiane M Rauch, Senthil Damodaran, Jennifer K Litton, Jennifer A Wargo, Gabriel N Hortobagyi, Andrew Futreal, Ignacio I Wistuba, Ryan Sun, Stacy L Moulder, Elizabeth A Mittendorf
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Di Ai, Jun Yao, Fei Yang, Lei Huo, Hui Chen, Wei Lu, Luisa Maren Solis Soto, Mei Jiang, Maria Gabriela Raso, Shufang Wang, Diana Bell, Jinsong Liu, Huamin Wang, Dongfeng Tan, Carlos Torres-Cabala, Qiong Gan, Yun Wu, Constance Albarracin, Mien-Chie Hung, Funda Meric-Bernstam, Ignacio I Wistuba, Victor G Prieto, Aysegul A Sahin, Qingqing Ding
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (4) (2020)
Adrienne G Waks, Daniel G Stover, Jennifer L Guerriero, Deborah Dillon, William T Barry, Evisa Gjini, Christina Hartl, Wesley Lo, Jennifer Savoie, Jane Brock, Robert Wesolowski, Zaibo Li, Adrienne Damicis, Anne V Philips, Yun Wu, Fei Yang, Amy Sullivan, Patrick Danaher, Heather Ann Brauer, Wafa Osmani, Mikel Lipschitz, Katherine A Hoadley, Michael S Goldberg, Charles M Perou, Scott Rodig, Eric P Winer, Ian E Krop, Elizabeth A Mittendorf, Sara M Tolaney
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (15) (2019)
Rama Soundararajan, Jared J Fradette, Jessica M Konen, Stacy Moulder, Xiang Zhang, Don L Gibbons, Navin Varadarajan, Ignacio I Wistuba, Debasish Tripathy, Chantale Bernatchez, Lauren A Byers, Jeffrey T Chang, Alejandro Contreras, Bora Lim, Edwin Roger Parra, Emily B Roarty, Jing Wang, Fei Yang, Michelle Barton, Jeffrey M Rosen, Sandurai A Mani
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy. Cancers 11 (5) (2019)
Sunil Acharya, Jun Yao, Ping Li, Chenyu Zhang, Frank J Lowery, Qingling Zhang, Hua Guo, Jingkun Qu, Fei Yang, Ignacio I Wistuba, Helen Piwnica-Worms, Aysegul A Sahin, Dihua Yu
Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer. Cancer research 79 (16) (2019)

Fei Yang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fei Yang